Merck Announces 340B Refunds

by admin | December 24, 2013 10:40 am

Pharmaceutical manufacturer Merck Sharp & Dohme Corp. has announced it will give refunds to 340B providers that bought certain products between 2002 and 2013. [ms-protect-content id=”2799″] The refunds are a result of a recently recalculated Average Manufacturer Price and Best Price values.

The items eligible for refunds include Remeron, Desogen, Implanaon, NuvaRing, Mircette, Cyclessa, Follistim, among others. A full list of products with corresponding national drug codes and relevant time frames is available here[1].

The company will be reaching out to 340B covered entities that are due refunds. Hospitals should direct inquiries to Organon_340B_Refund@merck.com. [/ms-protect-content] 

Source URL: https://340bemployed.org/merck-announces-340b-refunds/

---